About Douglas Berger Psychiatrist Tokyo

Dr. Douglas Berger, M.D., Ph.D., Meguro Counseling Center Director

Dr. Douglas Berger, M.D., Ph.D. Dr. Doug Berger is a graduate of New York Medical College where he completed a 4-year residency program in psychiatry.

Dr. Berger came to Japan as a medical exchange student and psychiatric researcher at the Tokai University School of Medicine on a research fellowship from the Matsumae International Foundation. He later returned to Japan to do further psychiatric research at the Tokyo University Department of Psychosomatic Medicine and the Tokyo Institute of Psychiatry. Dr. Berger speaks native-level Japanese and regularly conducts psychotherapy for mixed-cultural couples as well as the local Japanese community. This page lists Dr. Berger’s research activity, and this page is an archive of community education articles for the Tokyo Families Magazine written by Dr. Berger. Dr. Berger also works extensively with children as Director of the Tokyo Child & Adolescent Counseling Service. Dr. Berger is a legal permanent resident of Japan.

He then finished a fellowship in Psychosomatic Medicine at the Albert Einstein College of Medicine. Now based in Tokyo, he had served on the Faculty of the Albert Einstein College of Medicine Department of Psychiatry in New York as an Assistant Professor of Psychiatry and licensed practicing U.S. physician. Dr. Berger’s Japanese qualifications include a Ph.D. from the University of Tokyo School of Medicine received for psychiatric research done while at the Tokyo University Department of Psychosomatic Medicine. And now, Dr. Douglas Berger is a fully bilingual American board certified psychiatrist,  as well as the Director of the Tokyo Meguro Counseling Center.

Articles by Douglas Berger, M.D., Ph.D. for Tokyo Families magazine.

Click here to see a full list of articles.

Credential Verifications

Dr. Berger’s medical degree is from the United States, he is well-versed in the use of psychiatric medication and can guide the use of psychiatric medications integrated with psychotherapy through the physicians affiliated with his counseling practice (he does not directly practice medical care in Japan). Further information on Dr. Berger can be seen on his personal home page as well as the Tokyo Meguro Counseling Center’s page.

Publications by Dr. Douglas Berger, psychiatrist in Tokyo

Berger D: DOUBLE-BLINDING AND BIAS IN MEDICATION AND COGNITIVE-BEHAVIORAL THERAPY TRIALS FOR MAJOR DEPRESSIVE DISORDER, F1000Research 2016, 4:638 (doi: 10.12688/f1000research.6953.2). U.S. National Library of Medicine version.

Berger D: DOUBLE BLINDING REQUIREMENT FOR VALIDITY CLAIMS IN COGNITIVE-BEHAVIORAL THERAPY INTERVENTION TRIALS FOR MAJOR DEPRESSIVE DISORDER. Analysis of Hollon S, et al., Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomized clinical trial, F1000Research 2015, 4:639 (doi: 10.12688/f1000research.6954.1). U.S. National Library of Medicine version.

Contact Douglas Berger psychiatrist Tokyo by visiting this page

Dr. Jeste suggests “individuals might be trained to modulate brain activity with real-time functional MRI”: https://t.co/VGi9Qe0eTf. Only who would pay for the MRI technician/clinician & machine time? Us: https://t.co/2cyfo9FRgl, https://t.co/eGw7GaNOQn, https://t.co/K6iHnNBhQ1

Tokyo Counseling Center: Does DBT attenuate amygdala hyperactivity? https://t.co/qcTK7Bjntu

Tokyo Counseling Service: could effects mindfulness based therapy be due to placebo? https://t.co/BgVRmysFTA

Tokyo Counseling Center: Virtual Reality and randomized controlled trials https://t.co/E0SZmBt6bg

Wallis says Virtual Reality completed a randomized controlled trial: https://t.co/Z7TcEDJOmT. But you can't subject blind or have blind placebo in a VR trial that treats conditions w/subjective endpoints. Us https://t.co/iKvQ96AhM8 https://t.co/eGw7GaNOQn https://t.co/ymaLpFdrzz

Load More...

Here in our location in Japan & China, people wake up early every morning and do Tai Chi, there is no need advice from a medical doctor nor weave this into billing patients or insurance companies. Us: https://t.co/WLIjKdXqXL, https://t.co/RyG3aQt9vL, https://t.co/J7ZPFKUqAp.

Patients living well is great; over-selling therapy not supported by double-blind placebo studies (like mindfulness) is questionable. https://t.co/UE8stGua6q

Load More...